Method of Managing Metabolic Syndrome

• US 20110251659A1
• Filed: 04/04/2011
• Published: 10/13/2011
• Est. Priority Date: 04/09/2010
• Status: Abandoned Application

• Current Assignee: Marvin Prescott
• Original Assignee: Marvin Prescott
• Inventors: Prescott, Marvin
• Application Number:
  US13/079,627
• Publication Number:
  US 20110251659A1
• Time in Patent Office: Days
• US Class Current: 607/89
• CPC Class Codes: A61N 2005/0645 Applicators worn by the patient
• CPC Class Codes: A61N 2005/0652 Arrays of diodes
• CPC Class Codes: A61N 5/0616 Skin treatment other than tanning
• CPC Class Codes: A61N 5/067 using laser light

Abstract

A method is provided for treating metabolic syndrome with the use of a portable, non-invasive light-generating device. A laser beam is directed onto adipose tissue to reduce glucose and triglyceride levels through the activation of adiponectin. The laser beam is directed in accordance with a light regimen that is prescribed by a healthcare provide based one or more measured metabolic syndrome parameters of the patient.

Claims

1. A method of using a light-generating device for managing metabolic syndrome in a patient, the device including a light source for generating low power light, a power source for powering the light source, a proximity sensor for determining a proximity of the device to the patient, a parameter sensor for measuring a metabolic syndrome parameter of the patient, and a programmable controller for selectively enabling the light source of the device according to a prescribed light regimen, the method comprising:

attaching the device to a body part of the patient, the body part having underlying adipose tissue; and

selectively enabling the device according to the prescribed light regimen to direct a beam of low power light from the device onto the body part of the patient, the prescribed light regimen based on the measured metabolic syndrome parameter of the patient.

2. The method of claim 1, wherein the body part includes a stomach visceral adipose area, a thigh area, and/or an upper leg area.

3. The method of claim 1, wherein the light source includes a vertical cavity surface emitting laser diode and/or a light emitting diode.

4. The method of claim 3, wherein the light source has a wavelength of 850 nm and a power of 9 to 12 mW.

5. The method of claim 1, wherein the power source includes a rechargeable battery, and wherein the device includes a focusing lens for focusing the low power light generated by the light source.

6. The method of claim 1, wherein the light regimen includes a plurality of emission periods during which the low power light is directed towards the body part, each of the plurality of emission periods separated from each other by an interval period during which no low power light is generated.

7. The method of claim 6, wherein each of the plurality of emission periods is two minutes in length, and wherein each interval period is between two and sixteen minutes length.

8. The method of claim 1, further comprising, communicating when the proximity sensor is within a threshold distance of the patient'"'"'s body to a healthcare provider of the patient via wireless communication.

9. The method of claim 1, further comprising, continuing the prescribed light regimen until the metabolic syndrome parameter measured by the device is below a threshold.

10. A method of treating a patient, comprising:

measuring a metabolic syndrome parameter of the patient using a non-flexible light-generating device, the device including a plurality of low power lasers for generating a low power light beam, a rechargeable power source for powering the plurality of low power lasers, and a proximity sensor for communicating a distance between the sensor and the visceral area of the patient to a healthcare provider, the device contoured to match the visceral adipose area of the patient;

attaching the device to the visceral adipose area of the patient using a bandage; and

operating the device according to a light regimen to direct the low power light beam on the visceral area of the patient.

11. The method of claim 10, wherein the plurality of lasers are vertical cavity surface emitting laser diodes.

12. The method of claim 10, wherein the power source is recharged when the device is not attached to the patient.

13. The method of claim 10, further comprising, during operation of the device, communicating when the proximity sensor is within a threshold distance of the patient'"'"'s body to the healthcare provider via wireless communication.

14. The method of claim 10, wherein the light regimen includes a plurality of emission periods separated from each other by an interval period, and wherein operating the device according to the light regimen includes directing the low power light beam on the visceral adipose area during each emission period, and not generating the low power light beam during each interval period.

15. The method of claim 10, further comprising, continuing operation of the device according to the light regimen until the metabolic syndrome parameter measured by the device is below a threshold.

16. A method of treating a patient having metabolic syndrome with a non-flexible light-generating device, the device including a low power laser that emanates a low power light beam directed towards a visceral area of the patient'"'"'s body, a rechargeable power source for powering the low power laser, a proximity sensor for measuring a proximity of the device to the visceral area of the patient'"'"'s body, the proximity sensor communicatively coupled to a communication device of a healthcare provider, and a parameter sensor for measuring one or more metabolic syndrome parameters of the patient, the device contoured to match the visceral area of the patient, the method comprising:

attaching the device to a visceral adipose area of the patient;

determining a light regimen of the device based on the one or more metabolic syndrome parameters of the patient measured by the device, the determined light regimen including a plurality of emission periods during which low power light is directed towards the visceral adipose area, each of the plurality of emission periods separated from each other by an interval period during which no low power light is generated; and

operating the device according to the light regimen to direct the low power light on to the visceral area of the patient, wherein the operating includes enabling the low power laser of the device during each of the plurality of emission periods, and disabling the low power laser of the device during each interval period.

17. The method of claim 16, wherein each of the plurality of emission periods has a duration of two minutes, and wherein each interval period has a duration of two to sixteen minutes.

18. The method of claim 16, wherein the laser has a wavelength of 850 nm and a power of 9 to 12 mW.

19. The method of claim 16, wherein the one or more metabolic syndrome parameters include blood glucose level, blood triglyceride level, blood cholesterol level and/or blood lipoprotein level.

20. The method of claim 16, wherein the device has a contour that matches a visceral region of a human body, and wherein the device is attached to the visceral area of the patient'"'"'s body with one or more flexible bandages.